JAMA Network Home
Sign In
Viewpoint

Muscarinic Receptor Activators—What Is Their Place in Clinical Care?

JAMA Psychiatry 10.1001/jamapsychiatry.2025.3636

December 03, 2025 at 11:00 AM EST

Read the full article

This Viewpoint discusses the role of muscarinic receptor activators in the treatment of schizophrenia.

Corresponding Author: Christoph U. Correll, MD, Psychiatry Research, The Zucker Hillside Hospital, 75-59 263rd St, Glen Oaks, NY 11004 (ccorrell@northwell.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2025.3636?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120325

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks